Everolimus in Anaplastic Thyroid Cancer: A Case Series

Background: Anaplastic thyroid cancer (ATC) is a very aggressive disease and accounts for over 50% of thyroid-cancer related deaths. mTOR inhibition has shown anti-tumor activity in ATC. We report our experience treating patients with ATC with everolimus off-protocol. Methods: Patients with confirme...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Ethan J., Hanna, Glenn J., Chau, Nicole, Rabinowits, Guilherme, Haddad, Robert, Margalit, Danielle N., Schoenfeld, Jonathan, Tishler, Roy B., Barletta, Justine A., Nehs, Matthew, Janne, Pasi, Huang, Julian, Groden, Phillip, Kacew, Alec, Lorch, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399130/
https://www.ncbi.nlm.nih.gov/pubmed/30863722
http://dx.doi.org/10.3389/fonc.2019.00106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399130/
https://www.ncbi.nlm.nih.gov/pubmed/30863722
http://dx.doi.org/10.3389/fonc.2019.00106

Ejemplares similares